Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
about
Quality of life in patients with chronic thromboembolic pulmonary hypertensionAdaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands.Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension.The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension.Quality of life as a prognostic marker in pulmonary arterial hypertensionSex differences in response to tadalafil in pulmonary arterial hypertension.Building the case for novel clinical trials in pulmonary arterial hypertensionCollagen Metabolism Biomarkers and Health Related Quality of Life in Pulmonary Arterial HypertensionHealth-related Quality of Life and Survival in Pulmonary Arterial Hypertension.Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?A study of clinical and physiological relations of daily physical activity in precapillary pulmonary hypertension.Health-Related Quality of Life in Pulmonary Hypertension and Its Clinical Correlates: A Cross-Sectional Study.Sexual health and health-related quality of life among women with pulmonary arterial hypertension
P2860
Q26748611-74B920DC-628B-4F0E-A377-CE149BA9966AQ27342609-70846DBE-E2DE-425E-9C6B-ED64CCEB3DA2Q30251818-A684BD62-2CFC-4C30-9A06-0FE8807E6093Q33788447-E82158ED-6DF5-43C4-9069-2827A1AC5249Q34207690-92A6113B-F5A7-4AC2-B738-4FB4A83DCBD4Q34840330-F52837BE-D382-4426-A586-E7C0A9221952Q35005853-3597AF1B-A573-4247-9793-1C73A479945FQ36051659-A345BE30-373B-4D90-891C-36B92484B47EQ36490169-0A6D127B-BEA2-467A-8465-560AAAA6FDBBQ38525952-7E4E61F7-A19B-4A7F-AB96-92D1F4975C78Q47847965-2642C9BD-0BC2-4688-AD4C-690238B86106Q55000190-842E7C44-B9C2-454B-9486-55DEA097F0C6Q58737022-61CA4F59-1C86-4CFA-AF9F-A5978811DEFC
P2860
Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Patient-reported outcomes asse ...... mbolic pulmonary hypertension.
@ast
Patient-reported outcomes asse ...... mbolic pulmonary hypertension.
@en
type
label
Patient-reported outcomes asse ...... mbolic pulmonary hypertension.
@ast
Patient-reported outcomes asse ...... mbolic pulmonary hypertension.
@en
prefLabel
Patient-reported outcomes asse ...... mbolic pulmonary hypertension.
@ast
Patient-reported outcomes asse ...... mbolic pulmonary hypertension.
@en
P2093
P2860
P921
P356
P1433
P1476
Patient-reported outcomes asse ...... mbolic pulmonary hypertension.
@en
P2093
Colm McCabe
Linda Sharples
Maxine Bennett
Natalie Doughty
Robert MacKenzie Ross
P2860
P304
P356
10.1378/CHEST.12-2443
P407
P577
2013-08-01T00:00:00Z